Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets

被引:132
作者
Mueller, W
Hartmann, C
Hoffmann, A
Lanksch, W
Kiwit, J
Tonn, J
Veelken, J
Schramm, J
Weller, M
Wiestler, OD
Louis, DN
von Deimling, A
机构
[1] Humboldt Univ, Dept Neuropathol, Berlin, Germany
[2] Humboldt Univ, Dept Neurosurg, Berlin, Germany
[3] Helios Kliniken GmbH, Dept Neurosurg, Buch, Germany
[4] Univ Munich, Dept Neurosurg, Munich, Germany
[5] Vivantes Klinikum Neukolln, Dept Neurosurg, Berlin, Germany
[6] Univ Bonn, Med Ctr, Dept Neurosurg, D-5300 Bonn, Germany
[7] Univ Tubingen, Dept Neurol, D-7400 Tubingen, Germany
[8] Univ Bonn, Med Ctr, Dept Neuropathol, D-5300 Bonn, Germany
[9] Massachusetts Gen Hosp, Mol Neurooncol & Pathol Labs, Boston, MA 02114 USA
[10] Harvard Univ, Sch Med, Boston, MA USA
关键词
D O I
10.1016/S0002-9440(10)64183-1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Oligoastrocytomas are heterogeneous tumors that have molecular features that overlap with either oligodendrogliomas or astrocytomas. Differences in the frequency of chromosomal losses of 1p and 19q in oligodendrogliomas are related to tumor location, with a low rate of allelic loss in tumors of the temporal and a high rate in tumors of the frontal, parietal, and occipital lobes. To test the possibility of regional molecular heterogeneity in oligoastrocytoma, we examined a series of 203 gliomas including 68 oligoastrocytomas and two control groups of 73 oligodendrogliomas and 62 astrocytomas for allelic losses of chromosomal arms 1p and 19q, and TP53 mutations, and compared these data with tumor localization. Common molecular alterations were found in oligodendrogliomas and oligoastrocytoma arising in extratemporal sites. In respect to the molecular parameters analyzed, temporal oligoastrocytomas were either indistinguishable from astrocytoma or similar to temporal oligodendrogliomas. Oligodendroglial neoplasms can thus be separated into three molecular subsets, two of which include lesions with the morphological features of oligodendrogliomas and oligoastrocytomas and one resembling temporal oligoastrocytoma. Molecular subclassification thus unifies previous findings about prognosis, behavior, response to therapy, genotype, and location in oligodendroglial tumors.
引用
收藏
页码:313 / 319
页数:7
相关论文
共 40 条
  • [1] [Anonymous], 2000, World Health Organisation Classification of Tumours: Pathology and genetics of tumours of the nervous system
  • [2] [Anonymous], 1989, Pathology of tumours of the nervous system, ed
  • [3] Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas
    Bauman, GS
    Ino, Y
    Ueki, K
    Zlatescu, MC
    Fisher, BJ
    Macdonald, DR
    Stitt, L
    Louis, DN
    Cairncross, JG
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (03): : 825 - 830
  • [4] MOLECULAR ANALYSIS OF CHROMOSOME-1 ABNORMALITIES IN HUMAN GLIOMAS REVEALS FREQUENT LOSS OF 1P IN OLIGODENDROGLIAL TUMORS
    BELLO, MJ
    VAQUERO, J
    DECAMPOS, JM
    KUSAK, ME
    SARASA, JL
    SAEZCASTRESANA, J
    PESTANA, A
    REY, JA
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (02) : 172 - 175
  • [5] BENDER B, 1994, BIOTECHNIQUES, V16, P204
  • [6] Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas
    Cairncross, JG
    Ueki, K
    Zlatescu, MC
    Lisle, DK
    Finkelstein, DM
    Hammond, RR
    Silver, JS
    Stark, PC
    Macdonald, DR
    Ino, Y
    Ramsay, DA
    Louis, DN
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (19) : 1473 - 1479
  • [7] PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo
    Dai, C
    Celestino, JC
    Okada, Y
    Louis, DN
    Fuller, GN
    Holland, EC
    [J]. GENES & DEVELOPMENT, 2001, 15 (15) : 1913 - 1925
  • [8] THE TREATMENT OF OLIGODENDROGLIOMAS AND MIXED OLIGODENDROGLIOMA-ASTROCYTOMAS WITH PCV CHEMOTHERAPY
    GLASS, J
    HOCHBERG, FH
    GRUBER, ML
    LOUIS, DN
    SMITH, D
    RATTNER, B
    [J]. JOURNAL OF NEUROSURGERY, 1992, 76 (05) : 741 - 745
  • [9] HART MN, 1974, CANCER, V33, P134, DOI 10.1002/1097-0142(197401)33:1<134::AID-CNCR2820330120>3.0.CO
  • [10] 2-I